Cargando…

Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre

BACKGROUND: There is a paucity of literature about the benefits of bone-targeted agents for breast cancer patients with bone metastases treated in the non-trial setting. We explored the incidence, consequences, and treatment of bone metastases at a single cancer centre. METHODS: Electronic records o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuchuk, I., Hutton, B., Moretto, P., Ng, T., Addison, C.L., Clemons, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723382/ https://www.ncbi.nlm.nih.gov/pubmed/26909284 http://dx.doi.org/10.1016/j.jbo.2013.09.001

Ejemplares similares

Incidence and consequences of bone metastases in lung cancer patients
por: Kuchuk, Michael, et al.
Publicado: (2013)

Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
por: Simos, Demetrios, et al.
Publicado: (2013)

Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey
por: Hutton, Brian, et al.
Publicado: (2013)

A national portfolio of bone oncology trials—The Canadian experience in 2012
por: Kuchuk, I., et al.
Publicado: (2012)

A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer
por: Hutton, Brian, et al.
Publicado: (2013)

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
por: Hilton, J.F., et al.
Publicado: (2017)

Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients
por: Beltran-Bless, A., et al.
Publicado: (2021)

Effects of de-escalated bisphosphonate therapy on the Functional Assessment of Cancer Therapy-Bone Pain, Brief Pain Inventory and bone biomarkers
por: Kuchuk, Iryna, et al.
Publicado: (2013)

Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists
por: Kuchuk, Iryna, et al.
Publicado: (2013)

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer
por: Arnaout, Angel, et al.
Publicado: (2015)

A primer of bone metastases management in breast cancer patients
por: Petrut, B., et al.
Publicado: (2008)

De-escalated administration of bone-targeted agents in patients with breast and prostate cancer—A survey of Canadian oncologists
por: Hutton, Brian, et al.
Publicado: (2013)

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey
por: AlZahrani, Mashari, et al.
Publicado: (2020)

Does estrogen play a role in response to adjuvant bone-targeted therapies?
por: Russell, Kent, et al.
Publicado: (2013)

Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey
por: Alzahrani, Mashari, et al.
Publicado: (2021)

Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients–preliminary results
por: Fralick, M., et al.
Publicado: (2012)

Detection of PIK3CA Mutations in Breast Cancer Bone Metastases
por: Daneshmand, Manijeh, et al.
Publicado: (2012)

Strategies for obtaining bone biopsy specimens from breast cancer patients – Past experience and future directions
por: Ibrahim, Mohammed F.K., et al.
Publicado: (2016)

Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer
por: Zhao, Huijun, et al.
Publicado: (2023)

A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer
por: Addison, C.L., et al.
Publicado: (2016)

Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis
por: Gong, Yue, et al.
Publicado: (2018)

Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
por: Zhu, Xiaofu, et al.
Publicado: (2014)

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
por: Clemons, Mark, et al.
Publicado: (2021)

Bone metastases: Causes, consequences and therapeutic opportunities
por: Perez-Garcia, Jose, et al.
Publicado: (2013)

Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer
por: Tu, Megan M., et al.
Publicado: (2021)

Management of solitary and multiple brain metastases from breast cancer
por: Willett, Addison, et al.
Publicado: (2015)

Therapeutic targets for bone metastases in breast cancer
por: Clézardin, Philippe
Publicado: (2011)

Breast cancer bone metastases: an orthopedic emergency
por: Piccioli, Andrea
Publicado: (2013)

Prevention and Treatment of Bone Metastases in Breast Cancer
por: Carla, Ripamonti, et al.
Publicado: (2013)

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
por: Peters, Cedric, et al.
Publicado: (2021)

Laparoscopic thermoablation of colorectal cancer metastases to the liver – new experience of the centre
por: Murawa, Dawid, et al.
Publicado: (2012)

Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers
por: Cole, Katherine Marie, et al.
Publicado: (2021)

Rare breast malignancies and review of literature: A single centres experience
por: Ng, Cho Ee, et al.
Publicado: (2015)

Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?
por: Russell, Kent, et al.
Publicado: (2012)

The clinical course of bone metastases from breast cancer.
por: Coleman, R. E., et al.
Publicado: (1987)

Role of TGF-β in breast cancer bone metastases
por: Chiechi, Antonella, et al.
Publicado: (2013)

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients
por: Winczura, Piotr, et al.
Publicado: (2015)

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events
por: Addison, Christina L., et al.
Publicado: (2014)

Adrenal metastases – long-term results of surgical treatment, single-centre experience
por: Samsel, Radosław, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_46qeqtqg6vvno0fpb2029m44fd